Event Details
The company has scheduled a conference call with analysts and investors to discuss its unaudited financial results for the quarter and half year ended September 30, 2026 (Q2 FY27).
Conference Call Schedule
- Day and Date: Friday, October 16, 2026
- Time: 04:00 PM IST
- Meeting Type: Conference Call - Group Meet
- Scheduled for: Investors/Analysts
Management Participants
The conference call will feature:
- Sandeep Rao, Managing Director & Chief Executive Officer
- Sarat Kumar, Chief Financial Officer
Dial-in Details
- Universal Access Numbers: +91 22 6280 1346, +91 22 7115 8247
- Diamond Pass (for early registration): Available via provided link
Additional Information
The conference call information will also be available on the company's website at: https://solara.co.in/investor-relations/schedule-of-investors-meet-and-investors-presentations/
Company Description
The document describes the company as "Pure play APIs" (Active Pharmaceutical Ingredients).
#Tags: #SolaraActivePharmaSciences #Q2FY27Results #InvestorConferenceCall #SEBIDisclosure #RegulatoryCompliance #Neutral